NEW YORK (Reuters Health) – The Decipher genomic classifier (GC) is a promising tool to help determine which men will benefit from hormone therapy in addition to salvage radiation after radical prostatectomy, researchers say. “These findings are the first solid pieces of evidence to lead to a practice change,” Dr. […]